Melero I - Search Results

1

Advances in immunotherapy for hepatocellular carcinoma.

Sangro B, Sarobe P, Hervás-Stubbs S, Melero I. Sangro B, et al. Among authors: melero i. Nat Rev Gastroenterol Hepatol. 2021 Aug;18(8):525-543. doi: 10.1038/s41575-021-00438-0. Epub 2021 Apr 13. Nat Rev Gastroenterol Hepatol. 2021. PMID: 33850328 Free PMC article. Review.

2

Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas.

Melero I, Duarte M, Ruiz J, Sangro B, Galofré J, Mazzolini G, Bustos M, Qian C, Prieto J. Melero I, et al. Gene Ther. 1999 Oct;6(10):1779-84. doi: 10.1038/sj.gt.3301010. Gene Ther. 1999. PMID: 10516729

3

Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12.

Barajas M, Mazzolini G, Genové G, Bilbao R, Narvaiza I, Schmitz V, Sangro B, Melero I, Qian C, Prieto J. Barajas M, et al. Among authors: melero i. Hepatology. 2001 Jan;33(1):52-61. doi: 10.1053/jhep.2001.20796. Hepatology. 2001. PMID: 11124820 Free article.

4

Genetic heterogeneity in the toxicity to systemic adenoviral gene transfer of interleukin-12.

Mazzolini G, Narvaiza I, Pérez-Diez A, Rodriguez-Calvillo M, Qian C, Sangro B, Ruiz J, Prieto J, Melero I. Mazzolini G, et al. Among authors: melero i. Gene Ther. 2001 Feb;8(4):259-67. doi: 10.1038/sj.gt.3301387. Gene Ther. 2001. PMID: 11313799 Free article.

5

Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunity.

Casares N, Lasarte JJ, de Cerio AL, Sarobe P, Ruiz M, Melero I, Prieto J, Borrás-Cuesta F. Casares N, et al. Among authors: melero i. Eur J Immunol. 2001 Jun;31(6):1780-9. doi: 10.1002/1521-4141(200106)31:6<1780::aid-immu1780>3.0.co;2-i. Eur J Immunol. 2001. PMID: 11385623 Free article.

6

Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignancies.

Schmitz V, Qian C, Ruiz J, Sangro B, Melero I, Mazzolini G, Narvaiza I, Prieto J. Schmitz V, et al. Among authors: melero i. Gut. 2002 Jan;50(1):130-5. doi: 10.1136/gut.50.1.130. Gut. 2002. PMID: 11772981 Free PMC article. Review.

7

Gene therapy of primary and metastatic liver tumors.

Prieto J, Qian C, Melero I, Sangro B, Mazzolini G, Narvaiza I, Barajas M. Prieto J, et al. Among authors: melero i. Med Sci Monit. 2001 May;7 Suppl 1:76-7. Med Sci Monit. 2001. PMID: 12211755 Free article. No abstract available.

8

The promise of gene therapy in gastrointestinal and liver diseases.

Prieto J, Herraiz M, Sangro B, Qian C, Mazzolini G, Melero I, Ruiz J. Prieto J, et al. Among authors: melero i. Gut. 2003 May;52 Suppl 2(Suppl 2):ii49-54. doi: 10.1136/gut.52.suppl_2.ii49. Gut. 2003. PMID: 12651882 Free PMC article. Review.

9

Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses.

Sarobe P, Lasarte JJ, Zabaleta A, Arribillaga L, Arina A, Melero I, Borrás-Cuesta F, Prieto J. Sarobe P, et al. Among authors: melero i. J Virol. 2003 Oct;77(20):10862-71. doi: 10.1128/jvi.77.20.10862-10871.2003. J Virol. 2003. PMID: 14512536 Free PMC article.

10

CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination.

Casares N, Arribillaga L, Sarobe P, Dotor J, Lopez-Diaz de Cerio A, Melero I, Prieto J, Borrás-Cuesta F, Lasarte JJ. Casares N, et al. Among authors: melero i. J Immunol. 2003 Dec 1;171(11):5931-9. doi: 10.4049/jimmunol.171.11.5931. J Immunol. 2003. PMID: 14634104 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

356 results

Search Page